Two drugs used for decades to treat inflammatory forms of arthritis may also benefit some people with hand osteoarthritis (OA). That’s according to two new studies presented at the 2019 American College of Rheumatology (ACR) annual meeting in early November in Atlanta.
Patient voices are critical to finding a cure for OA and other forms of arthritis. That’s the message Arthritis Foundation Osteoarthritis (OA) Programs Director Angie Botto-van Bemden, PhD, is sharing at the2019 annual European Congress of Rheumatology (EULAR)6月12日至15日，马德里。Continue readingOur Global Message to Strengthen Patient Voices Is Heard at EULAR
The Arthritis Foundation is partnering globally with other osteoarthritis (OA)-related patient advocacy organizations to develop consistent treatment management messaging for all health care providers (HCPs) who interact with OA patients. Currently, an OA patient may see different types of HCPs, depending on the stage of their disease and their location. It’s important that primary care doctors become familiar with all OA treatment options so they can work with patients to develop the best care plans.Continue readingProviding a Consistent Message for OA Disease Management
Globally,osteoarthritis(OA) is the third most rapidly rising condition associated with disability. We know the disease affects people of all ages, and given the current rate of population aging, it is estimated that the number of people who suffer from this disease will double in the next three decades. These are staggering statistics that we are actively trying to change.
Continue readingGlobal Survey Will Help Us Understand Patient Perceptions